The Prader-Willi Syndrome Association – USA

Aardvark Therapeutics, Inc. is a biopharmaceutical company based in San Diego, California, founded in 2017 by Tien Lee. The company focuses on developing and commercializing small molecule therapeutics specifically targeting obesity and rare genetic metabolic disorders. Its lead product, Bittera, is a first-in-class oral composition designed to selectively disrupt hunger signaling while regulating energy homeostasis, providing a novel treatment option that does not interfere with nutrient absorption. Through its innovative approach, Aardvark Therapeutics aims to offer effective and safe solutions for clinicians managing obesity-related diseases.